Baseline plasma chromogranin A levels in patients with well-differentiated neuroendocrine tumors of the pancreas: A potential predictor of postoperative recurrence. (Q51222358)
Jump to navigation
Jump to search
scientific article published on 29 December 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Baseline plasma chromogranin A levels in patients with well-differentiated neuroendocrine tumors of the pancreas: A potential predictor of postoperative recurrence. |
scientific article published on 29 December 2016 |
Statements
Baseline plasma chromogranin A levels in patients with well-differentiated neuroendocrine tumors of the pancreas: A potential predictor of postoperative recurrence. (English)
1 reference
Yoshihide Nanno
1 reference
Hirochika Toyama
1 reference
Ippei Matsumoto
1 reference
Kyoko Otani
1 reference
Sadaki Asari
1 reference
Tadahiro Goto
1 reference
Tetsuo Ajiki
1 reference
Yoh Zen
1 reference
Takumi Fukumoto
1 reference
Yonson Ku
1 reference
29 December 2016
1 reference
17
1 reference
2
1 reference
291-294
1 reference